Chronic lymohocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Erstveröffentlichung

2021

Authors

Eichhorst, B.

Robak, T.

Montserrat, E.

Ghia, P.

Niemann, C. U.

et al.

Wissenschaftlicher Artikel

Published in

Annals of Oncology ; 32 (2021), 1. - S. 23-33. - ISSN 0923-7534. - eISSN 1569-8041

Link to publication

https://dx.doi.org/10.1016/j.annonc.2020.09.019

Institutions

UKU. Institut für Experimentelle Tumorforschung

Subject headings

[Free subject headings]: chronic lymphocytic leukaemia | prognostic factors | individualised therapy | B-cell receptor inhibitors | BCL2 inhibitor | targeted treatment | CHRONIC LYMPHOCYTIC-LEUKEMIA | MINIMAL RESIDUAL DISEASE | OPEN-LABEL | CELL TRANSPLANTATION | PROGNOSTIC INDEX | CD38 EXPRESSION | TP53 MUTATION | CLL-IPI | RITUXIMAB | IBRUTINIB
[DDC subject group]: DDC 610 / Medicine & health

Metadata

Show full item record